Understanding The Clinical Research Organization and The Business of Falsifying Bioequivalence

Executive Summary Falsifying bioequivalence is commonly done by what is called clinical research organizations or CROs. Introduction A significant issue with falsifying bioequivalence is the companies paid to prove rather than test bioequivalence. These are called Clinical Research Organizations or CROs. Wait One Second… Why is The Article Not Viewable? You are seeing this text…

The Problems With Bioequivalence Drug Testing

Executive Summary Bioequivalence testing is much more complicated and fraught with limitations than generally understood. The World Health Organization and Generic Drug Production Introduction Patients are repeatedly told there is no difference between generics and brand-name drugs. How this assertion is proven tends to be left out of the conversation, and that is what we…

What Type of Information is Shared from Brand Name Manufacturer to the Generic Manufacturer?

Executive Summary What is shared by the brand name drug manufacturers with generic manufacturers is far different than generally assumed. Introduction Something that is little known except by those working in the pharmaceutical industry with generics is the process of developing a generic from a brand-name drug. I will focus on the information shared between…

Generic Drugs and the WHO’s Essential Medicine List

Executive Summary The idea behind the WHO’s Essential Medicines List was to promote local manufacturing, which has not occurred in smaller or larger countries. The World Health Organization and Generic Drug Production Introduction An important part of understanding generic drugs is understanding the World Health Organization’s Essential Drug List and program. The essential medicine list…

How Much of the Problem of Generic Drug Bioequivalence Is Due to Indian Manufacturing?

Executive Summary Bioequivalence is the similarity of a generic drug to the original. Generics have a known issue with bioequivalence that is often discussed separately from the topic of Indian manufacturing. Introduction Two issues that deeply intersect but are not discussed in unison are the significant variance between generics and the original drug and how…

The Difficulty in Finding Useful Canadian Pharmacies

Executive Summary Finding useful Canadian pharmacies is much more complicated than it initially appears. Introduction Trying to find acceptable Canadian pharmacies proved far more challenging than I imagined. Wait One Second… Why is The Article Not Viewable? You are seeing this text instead of the article because of two potential reasons. Reason #1: You are…

How Many Online Canadian Pharmacies Not Really Canadian?

Executive Summary Many supposedly Canadian online pharmacies are not actually Canadian and are based in India and sell Indian-manufactured drugs. Introduction Using Canadian pharmacies is very popular for US patients; however, not all “Canadian pharmacies” are actually in Canada, and some Canadian pharmacies specialize in selling drugs made in India, and while most Canadian pharmacies…

The Brightwork Method of Determining the Drug Source Rating

Executive Summary The pharmacy and the drug’s manufacturing location are significant in determining drug quality. Introduction The country of drug manufacture is one of the best ways of determining drug quality. We will review the transparency of drug manufacturing on different websites to support finding the best value and highest quality. Wait One Second… Why…

The Problem With India’s Sun and Aurobindo and Ranbaxy Pharma

Executive Summary Indian drugs are inexpensive, and this makes India a source that is interesting to many. This article covers the problems of major Indian drug manufacturers. Introduction Indian pharmacies offer excellent prices on drugs. However, there has been a long-term question regarding the reliability of the drugs from these pharmacies. This article investigates this…